Jyoti CNC Automation reports 31% revenue growth in Q2 FY27

Jyoti CNC Automation Limited announced strong financial results for the second quarter and first half of FY27. Standalone revenues grew by 31% year-on-year to INR588 crore. Profit After Tax (PAT) increased by 46% to INR115 crore. The company also highlighted a robust order book of INR5,082 crore, providing strong revenue visibility.

Strong Financial Performance in Q2 FY27

Jyoti CNC Automation Limited has reported robust financial performance for the second quarter and the first half of the financial year 2027 (FY27). The company’s standalone revenues demonstrated significant growth, increasing by 31% to INR588 crore in Q2 FY27 compared to the same period last year. This growth is attributed to strong demand across key sectors and improved operational performance.

Profitability Boost

The company also saw a substantial increase in profitability. Standalone Profit After Tax (PAT) for Q2 FY27 rose by 46% year-on-year, reaching INR115 crore. The EBITDA margin stood at 28%, reflecting operational efficiencies and effective cost management. This performance underscores the company’s ability to translate revenue growth into enhanced profitability.

Consolidated Results and Order Book

On a consolidated basis, revenue for Q2 FY27 stood at INR602 crore, a growth of 18.5% over Q2 FY26. The consolidated EBITDA margin was 21.8%, with PAT at INR73 crore. A key highlight for investors is the company’s healthy order book, which stood at INR5,082 crore as of September 30, 2026. This substantial order pipeline provides strong revenue visibility for the upcoming quarters, driven by demand from sectors like aerospace, defense, and automotive.

Operational Highlights and Future Outlook

During the quarter, Jyoti CNC dispatched approximately 1,900 machines, marking a historical high. The company is also set to commence operations at its new foundry soon, which is expected to further boost production capacity. With ongoing investments in R&D and capacity expansion, Jyoti CNC is well-positioned to capitalize on the growing demand in the manufacturing sector and contribute to India’s self-reliance goals.

Source: BSE

Previous Article

Gland Pharma reports 23% revenue growth and 58% PAT growth in Q2 FY27